CSS
APTO

Cubist Systematic Strategies’s Aptose Biosciences, Inc. APTO Stock Holding History

Cubist Systematic Strategies’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-150
Closed -$92K – 3916
2021
Q4 		$92K Buy
+150
New +$141K ﹤0.01% 3219
2019
Q3 		– Sell
-1
Closed -$1K – 2575
2019
Q2 		$1K Buy
+1
New +$920 ﹤0.01% 2426

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cubist Systematic Strategies's APTO Position: Q1 2022 in Review

Cubist Systematic Strategies sold out of Aptose Biosciences, Inc. (APTO) in Q1 2022, closing a stake of 150 shares — an estimated $92K sold.

Cubist Systematic Strategies first reported a position in APTO in Q2 2019 and held it in 2 quarters. The position peaked at $92K in Q4 2021. 52 funds tracked by Wall St. Rank hold APTO as of Q1 2022.

  • Cubist Systematic Strategies reported no remaining Aptose Biosciences, Inc. position as of Q1 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 150 Aptose Biosciences, Inc. shares in Q1 2022, an estimated $92K.
  • Cubist Systematic Strategies first reported a position in Aptose Biosciences, Inc. in Q2 2019 and held it in 2 quarters.
  • Cubist Systematic Strategies's Aptose Biosciences, Inc. position peaked at $92K in Q4 2021.
  • 52 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2022.

Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.